Martin Kovach

Martin Kovach

Education

University of California, Santa CruzPh.D. Environmental Studies

University of PennsylvaniaM.A. Philosophy

Yale UniversityB.A. English

Specialization

Antitrust and Competition
Class Certification
Intellectual Property
Pharmaceuticals
Complex Damages
Natural Resources & Environment
Insurance and Healthcare

Download CV

Dr. Martin Kovach is the Director of Pharmaceutical Analytics at OnPoint. He has extensive experience managing the production of expert reports from beginning to end—developing strategies and arguments, supervising research, collecting data and documents, conducting statistical analyses, drafting reports, and preparing for depositions and trials. He has been responsible for structuring and conducting the empirical analyses in more than fifty major pharmaceutical cases in the areas of intellectual property, antitrust, breach of contract, and deceptive marketing. He is an expert in the use of pharmaceutical data sources, pharmaceutical market dynamics, and pharmaceutical promotion. Other areas in which he has worked extensively include insurance, food and agriculture, and the environment. Dr. Kovach is co-author of Empirical Challenges in Pharma Litigation (2017). He has also conducted research into the environmental effects of persistent chemicals and published on the population effects of fishery restrictions.

OnPoint Book Release! Empirical Challenges in Pharma Litigation

Brexit’s Impact on Pharma: Possible effects on the geography of pharmaceutical R&D and the availability of drugs in the UK

The Cost of Opioid Abuse: A Review of Recent Estimates

The IMS-Quintiles Merger: A Window into the Future of Pharmaceutical R&D

Patent Proliferation: A 30-year increase in the number of patents per drug

Biologics Exclusivity and the TPP: An International Balancing Act

Biosimilar Conversion: How Slippery is the Slope?

Amgen v. Sandoz – Let’s Just Agree to Disagree